Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
31,110,398
-
Share change
-
-571,124
-
Total reported value
-
$307,998,792
-
Put/Call ratio
-
267%
-
Price per share
-
$9.90
-
Number of holders
-
89
-
Value change
-
-$7,898,896
-
Number of buys
-
46
-
Number of sells
-
35
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2016
As of 31 Dec 2016,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,110,398 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, Capital World Investors, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, Artal Group S.A., D. E. Shaw & Co., Inc., and ARK Investment Management LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.